Jalra-Trio_Tablets_-_Pack_of_2
Jalra-Trio_Tablets_-_Pack_of_2
Jalra-Trio_Tablets_-_Pack_of_2
Jalra-Trio_Tablets_-_Pack_of_2
Jalra-Trio_Tablets_-_Pack_of_2
Jalra-Trio_Tablets_-_Pack_of_2__undefined__undefined
Jalra-Trio Tablets - Pack of 2

₹366

View Available Offers

Final Price inclusive of all taxes

Free Delivery

Get it delivered in 3-6 days

size

10 tablets

Product Information

Country Of Origin

India


Ideal For

Triple Combination For Type 2 Diabetes Mellitus. Dpp-4 Inhibition, Sglt2 Inhibition, And Biguanide Action For Comprehensive Glycaemic Control.


Ingredients

Vildagliptin 100Mg, Dapagliflozin 10Mg, Metformin Hydrochloride 500Mg Sr


Pack Of

2


Type

Tablets

Product Description

  • Key Ingredients: This Sustained-Release Formulation Combines Vildagliptin 100Mg, Dapagliflozin 10Mg, And Metformin Hydrochloride 500Mg In Each Tablet For Comprehensive Diabetes Management.
  • Product Design: Pharmaceutical-Grade Tablets Manufactured By Usv Private Limited Under Schedule G Prescription Guidelines, Ensuring Quality And Safety Standards.
  • User Experience: Sustained-Release Technology Provides Controlled Medication Delivery Throughout The Day, Designed For Convenient Once-Daily Dosing As Directed By A Physician.
  • Versatile Occasion: Formulated For Oral Use In Adults As Part Of A Prescribed Diabetes Treatment Regimen Under Medical Supervision.
  • Quality Assurance: Manufactured By Exemed Pharmaceuticals Following Strict Pharmaceutical Standards, With Clear Labeling Of Active Ingredients And Dosage Information.
  • Ideal For: Prescription Medication Intended For Diabetic Patients Requiring Combination Therapy, To Be Kept Out Of Reach Of Children And Stored As Directed.